Cancer Control in Central and Eastern Europe: Current Situation and Recommendations for Improvement

Overview

Journal Oncologist

Publisher Oxford University Press

Specialty Oncology

Date 2016 Jul 13

PMID 27401890

Citations 21

Authors

Eduard Vrdoljak

Gyorgy Bodoky

Jacek Jassem

Razvan A Popescu

Jozef Mardiak

Robert Pirker

Tanja Cufer

Semir Beslija

Alexandru Eniu

Vladimir Todorovic

Katerina Kubackova

Galia Kurteva

Zorica Tomasevic

Agim Sallaku

Snezhana Smichkoska

Zarko Bajic

Branimir I Sikic

Affiliations

Soon will be listed here.

Abstract

Implications For Practice: Significant differences in cancer incidence and mortality have been observed between European countries. While the incidence of many cancer types is higher in Western European (WE) countries, the mortality is generally higher in Central and Eastern Europe (CEE). The primary purpose of this review was to describe the current status and trends of oncology care in the CEE region, to raise awareness among physicians, regulators, and payers, and to propose the most needed changes in order to make the oncology care in CEE closer to the WE standards.

Citing Articles

Analysis of the European Union's National Cancer Control Programs: Meeting the Needs of People with Intellectual Disabilities.

Kowalczyk O, Ambrocio R, Vukovic V, Denieffe S, Denny M Healthcare (Basel). 2025; 13(5).

PMID: 40077018 PMC: 11899318. DOI: 10.3390/healthcare13050456.

Cancer burden in Europe: a systematic analysis of the GLOBOCAN database (2022).

Elmadani M, Mokaya P, Omer A, Kiptulon E, Klara S, Orsolya M BMC Cancer. 2025; 25(1):447.

PMID: 40075331 PMC: 11905646. DOI: 10.1186/s12885-025-13862-1.

The Global, Regional, and National Burden of Tracheal, Bronchus, and Lung Cancer Caused by Smoking: An Analysis Based on the Global Burden of Disease Study 2021.

Zhang J, Tang J, Yang R, Chen S, Jian H, Zeng P Ann Glob Health. 2024; 90(1):77.

PMID: 39650717 PMC: 11623080. DOI: 10.5334/aogh.4572.

Challenges and controversies in resectable non-small cell lung cancer: a clinician's perspective.

Houda I, Dickhoff C, Uyl-de Groot C, Damhuis R, Reguart N, Provencio M Lancet Reg Health Eur. 2024; 38:100841.

PMID: 38476749 PMC: 10928275. DOI: 10.1016/j.lanepe.2024.100841.

Real-World Patterns and Decision Drivers of Radiotherapy for Lung Cancer Patients in Romania: RADIO-NET Study Results.

Georgescu M, Zahu R, Rusu P, Teodorescu G, Kacso G Diagnostics (Basel). 2022; 12(12).

PMID: 36553096 PMC: 9777374. DOI: 10.3390/diagnostics12123089.

References

Chang S, Long S, Kutikova L, Bowman L, Finley D, Crown W . Estimating the cost of cancer: results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000. J Clin Oncol. 2004; 22(17):3524-30. DOI: 10.1200/JCO.2004.10.170. View

Grau C, Defourny N, Malicki J, Dunscombe P, Borras J, Coffey M . Radiotherapy equipment and departments in the European countries: final results from the ESTRO-HERO survey. Radiother Oncol. 2014; 112(2):155-64. DOI: 10.1016/j.radonc.2014.08.029. View

Colditz G, Wolin K, Gehlert S . Applying what we know to accelerate cancer prevention. Sci Transl Med. 2012; 4(127):127rv4. PMC: 3343638. DOI: 10.1126/scitranslmed.3003218. View

Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh J, Comber H . Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013; 49(6):1374-403. DOI: 10.1016/j.ejca.2012.12.027. View

Bagnardi V, Rota M, Botteri E, Tramacere I, Islami F, Fedirko V . Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis. Br J Cancer. 2014; 112(3):580-93. PMC: 4453639. DOI: 10.1038/bjc.2014.579. View

Karim-Kos H, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh J . Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer. 2008; 44(10):1345-89. DOI: 10.1016/j.ejca.2007.12.015. View

De Angelis R, Sant M, Coleman M, Francisci S, Baili P, Pierannunzio D . Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study. Lancet Oncol. 2013; 15(1):23-34. DOI: 10.1016/S1470-2045(13)70546-1. View

Ligibel J, Alfano C, Courneya K, Demark-Wahnefried W, Burger R, Chlebowski R . American Society of Clinical Oncology position statement on obesity and cancer. J Clin Oncol. 2014; 32(31):3568-74. PMC: 4979237. DOI: 10.1200/JCO.2014.58.4680. View

Jemal A, Center M, DeSantis C, Ward E . Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 2010; 19(8):1893-907. DOI: 10.1158/1055-9965.EPI-10-0437. View

10.

Bosetti C, Bertuccio P, Malvezzi M, Levi F, Chatenoud L, Negri E . Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980. Ann Oncol. 2013; 24(10):2657-2671. DOI: 10.1093/annonc/mdt301. View

11.

Ades F, Senterre C, de Azambuja E, Sullivan R, Popescu R, Parent F . Discrepancies in cancer incidence and mortality and its relationship to health expenditure in the 27 European Union member states. Ann Oncol. 2013; 24(11):2897-902. DOI: 10.1093/annonc/mdt352. View

12.

Giacosa A, Barale R, Bavaresco L, Gatenby P, Gerbi V, Janssens J . Cancer prevention in Europe: the Mediterranean diet as a protective choice. Eur J Cancer Prev. 2012; 22(1):90-5. DOI: 10.1097/CEJ.0b013e328354d2d7. View

13.

Wolin K, Carson K, Colditz G . Obesity and cancer. Oncologist. 2010; 15(6):556-65. PMC: 3227989. DOI: 10.1634/theoncologist.2009-0285. View

14.

Bray F, Jemal A, Torre L, Forman D, Vineis P . Long-term Realism and Cost-effectiveness: Primary Prevention in Combatting Cancer and Associated Inequalities Worldwide. J Natl Cancer Inst. 2015; 107(12):djv273. PMC: 4673394. DOI: 10.1093/jnci/djv273. View

15.

La Vecchia C, Rota M, Malvezzi M, Negri E . Potential for improvement in cancer management: reducing mortality in the European Union. Oncologist. 2015; 20(5):495-8. PMC: 4425394. DOI: 10.1634/theoncologist.2015-0011. View

16.

Vrdoljak E, Torday L, Sella A, Leyman S, Bavbek S, Kharkevich G . Insights into cancer surveillance in Central and Eastern Europe, Israel and Turkey. Eur J Cancer Care (Engl). 2014; 24(1):99-110. DOI: 10.1111/ecc.12149. View

17.

Bray F, Ren J, Masuyer E, Ferlay J . Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2012; 132(5):1133-45. DOI: 10.1002/ijc.27711. View

18.

Goday A, Barneto I, Garcia-Almeida J, Blasco A, Lecube A, Gravalos C . Obesity as a risk factor in cancer: A national consensus of the Spanish Society for the Study of Obesity and the Spanish Society of Medical Oncology. Clin Transl Oncol. 2015; 17(10):763-71. DOI: 10.1007/s12094-015-1306-y. View

19.

Chino F, Peppercorn J, Taylor Jr D, Lu Y, Samsa G, Abernethy A . Self-reported financial burden and satisfaction with care among patients with cancer. Oncologist. 2014; 19(4):414-20. PMC: 3983822. DOI: 10.1634/theoncologist.2013-0374. View

20.

Vostakolaei F, Karim-Kos H, Janssen-Heijnen M, Visser O, Verbeek A, Kiemeney L . The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival. Eur J Public Health. 2010; 21(5):573-7. DOI: 10.1093/eurpub/ckq120. View